Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 809-920-4 | CAS number: 1047637-37-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 15 December 1993 - 25 January 1994
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 994
- Report date:
- 1994
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- Study from 1994
Test material
- Reference substance name:
- 2,2-bis(chloromethyl)trimethylene bis(bis(2-chloroethyl)phosphate)
- EC Number:
- 253-760-2
- EC Name:
- 2,2-bis(chloromethyl)trimethylene bis(bis(2-chloroethyl)phosphate)
- Cas Number:
- 38051-10-4
- Molecular formula:
- C13H24Cl6O8P2
- IUPAC Name:
- 2,2-bis(chloromethyl)propane-1,3-diyl tetrakis(2-chloroethyl) bis(phosphate)
- Details on test material:
- Product name: Amgard V6
Appearance: very pale straw coloured viscous liquid
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Dunkin-Hartley
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: David Hall Limited, Burton-on-Trent, UK
- Age at study initiation: 8 - 12 weeks old
- Weight at study initiation: 355 - 450 grams
- Housing: in groups of up to three, in solid floor polypropylene cages
- Diet: ad libitum (Guinea Pig FDI Diet)
- Water: ad libitum
- Acclimation period: minimum five days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19 - 22
- Humidity (%): 42 - 65
- Air changes (per hr): approximately 15
- Photoperiod (hrs dark / hrs light): 12h/12h
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- intradermal and epicutaneous
- Vehicle:
- other: Epicutaneous exposure undiluted (no vehicle), for intradermal exposure Acetone 6% in Arachis oil used as vehicle
- Concentration / amount:
- - Intradermal induction: sighting test with 1 and 5% w/v of the test substance in 6% acetone v/v in arachis oil, main test only with 5% w/v
- Epicutaneous induction: sighting test with 25, 50, 75 and 100 % v/v of the test material in acetone, main study only with 100 % v/v (undiluted)
- Epicutaneous challenge: sighting test with 25, 50, 75 and 100 % v/v of the test material in acetone, main study only with 75 and 100 % v/v (undiluted)
Challengeopen allclose all
- Route:
- epicutaneous, occlusive
- Vehicle:
- other: Epicutaneous exposure undiluted (no vehicle), for intradermal exposure Acetone 6% in Arachis oil used as vehicle
- Concentration / amount:
- - Intradermal induction: sighting test with 1 and 5% w/v of the test substance in 6% acetone v/v in arachis oil, main test only with 5% w/v
- Epicutaneous induction: sighting test with 25, 50, 75 and 100 % v/v of the test material in acetone, main study only with 100 % v/v (undiluted)
- Epicutaneous challenge: sighting test with 25, 50, 75 and 100 % v/v of the test material in acetone, main study only with 75 and 100 % v/v (undiluted)
- No. of animals per dose:
- - Sighting tests: 3 x 2 animals, to select concentrations for the main study
- Main study: 20 animals for the treatment, 10 as control - Details on study design:
- MAIN STUDY
- No. of exposures: 3 injections (intradermal) at Day 0, epicutaneous application at Day 7, epicutaneous challenge at Day 21
- Site: both intradermal and epicutaneous induction on skin site on right shoulder, epicutaneous challenge on right flank
- Exposure period: epicutaneous induction with 48 hours exposure, challenge with 24 hours exposure
- Frequency of applications: 1 intradermal, 2 epicutaneous (induction and challenge)
- Duration: 24 days (total)
- Evaluation: 24 and 48 hours after intradermal application, 1 and 24 hours after epicutaneous induction and 24, 48 and 72 hours after epicutaneous challenge
- Sodium laurylsulfate pretreatment (0.5 ml of a 10% solution in petrolatum) was used to enhance the irritant reaction on day 6 after the intradermal
induction. - Challenge controls:
- Vehicle applied on left flank, application similarl to treatment group
- Positive control substance(s):
- yes
- Remarks:
- recent historical control data with 2,4-dinitrochlorobenzene, alpha-hexycinnamaldehyde and 2-mercaptbenzthiazole were provided
Results and discussion
- Positive control results:
- 2,4-dichloronitrobenzene: intradermal induction conc. 0.5% in arachis oil, topical induction: 0.75% in abs. ethanol, challenge: 0.25% in abs. ethanol.:
9/10 positive
alpha-hexycinnamaldehyde (85%): intradermal induction conc. 25% in arachis oil, topical induction: 100%, challenge: 100% and 75% in arachis oil.:
2 studies: one 3/10 positive, one 7/10 positive
2-mercaptobenzthiazole: intradermal induction conc. 5% in arachis oil, topical induction: 50% in archis oil, challenge: 50 and 25% in arachis oil:
8/10 positive
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- other: Intradermal induction
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 5% w/v
- No. with + reactions:
- 20
- Total no. in group:
- 20
- Remarks on result:
- other: Reading: other: Intradermal induction. . Hours after challenge: 24.0. Group: test group. Dose level: 5% w/v. No with. + reactions: 20.0. Total no. in groups: 20.0.
- Reading:
- other: Intradermanl induction
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 5% w/v
- No. with + reactions:
- 20
- Total no. in group:
- 20
- Remarks on result:
- other: Reading: other: Intradermanl induction. . Hours after challenge: 48.0. Group: test group. Dose level: 5% w/v. No with. + reactions: 20.0. Total no. in groups: 20.0.
- Reading:
- other: Intradermal induction
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 0
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: other: Intradermal induction. . Hours after challenge: 24.0. Group: negative control. Dose level: 0. No with. + reactions: 0.0. Total no. in groups: 10.0.
- Reading:
- other: Intradermal induction
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 0
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: other: Intradermal induction. . Hours after challenge: 48.0. Group: negative control. Dose level: 0. No with. + reactions: 0.0. Total no. in groups: 10.0.
- Reading:
- other: Epicutaneous induction
- Hours after challenge:
- 1
- Group:
- test chemical
- Dose level:
- undiluted
- No. with + reactions:
- 16
- Total no. in group:
- 20
- Clinical observations:
- 2 animals found dead, one at Day 8 and one at Day 9
- Remarks on result:
- other: Reading: other: Epicutaneous induction. . Hours after challenge: 1.0. Group: test group. Dose level: undiluted. No with. + reactions: 16.0. Total no. in groups: 20.0. Clinical observations: 2 animals found dead, one at Day 8 and one at Day 9.
- Reading:
- other: Epicutaneous induction
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- undiluted
- No. with + reactions:
- 5
- Total no. in group:
- 20
- Clinical observations:
- 2 animals found dead, one at Day 8 and one at Day 9
- Remarks on result:
- other: Reading: other: Epicutaneous induction. . Hours after challenge: 24.0. Group: test group. Dose level: undiluted. No with. + reactions: 5.0. Total no. in groups: 20.0. Clinical observations: 2 animals found dead, one at Day 8 and one at Day 9.
- Reading:
- other: Epicutaneous induction
- Hours after challenge:
- 1
- Group:
- negative control
- Dose level:
- 0
- No. with + reactions:
- 7
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: other: Epicutaneous induction. . Hours after challenge: 1.0. Group: negative control. Dose level: 0. No with. + reactions: 7.0. Total no. in groups: 10.0.
- Reading:
- other: Epicutaneous induction
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 0
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: other: Epicutaneous induction. . Hours after challenge: 24.0. Group: negative control. Dose level: 0. No with. + reactions: 0.0. Total no. in groups: 10.0.
- Reading:
- other: Epicutaneous challenge
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- undiluted
- No. with + reactions:
- 2
- Total no. in group:
- 20
- Clinical observations:
- 2 animals found dead, one at Day 8 and one at Day 9
- Remarks on result:
- other: Reading: other: Epicutaneous challenge. . Hours after challenge: 24.0. Group: test group. Dose level: undiluted. No with. + reactions: 2.0. Total no. in groups: 20.0. Clinical observations: 2 animals found dead, one at Day 8 and one at Day 9.
- Reading:
- other: Epicutaneous challenge
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 75% v/v
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- 2 animals found dead, one at Day 8 and one at Day 9
- Remarks on result:
- other: Reading: other: Epicutaneous challenge. . Hours after challenge: 24.0. Group: test group. Dose level: 75% v/v. No with. + reactions: 0.0. Total no. in groups: 20.0. Clinical observations: 2 animals found dead, one at Day 8 and one at Day 9.
- Reading:
- other: Epicutaneous challenge
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- undiluted
- No. with + reactions:
- 1
- Total no. in group:
- 20
- Clinical observations:
- 2 animals found dead, one on Day 8 and one on Day 9
- Remarks on result:
- other: Reading: other: Epicutaneous challenge. . Hours after challenge: 48.0. Group: test group. Dose level: undiluted. No with. + reactions: 1.0. Total no. in groups: 20.0. Clinical observations: 2 animals found dead, one on Day 8 and one on Day 9.
- Reading:
- other: Epicutaneous challenge
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 75% v/v
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- 2 animals found dead, one on Day 8 and one on Day 9
- Remarks on result:
- other: Reading: other: Epicutaneous challenge. . Hours after challenge: 48.0. Group: test group. Dose level: 75% v/v. No with. + reactions: 0.0. Total no. in groups: 20.0. Clinical observations: 2 animals found dead, one on Day 8 and one on Day 9.
- Reading:
- other: Epicutaneous challenge
- Hours after challenge:
- 72
- Group:
- test chemical
- Dose level:
- undiluted
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- 2 animals found dead, one on Day 8 and one on Day 9
- Remarks on result:
- other: Reading: other: Epicutaneous challenge. . Hours after challenge: 72.0. Group: test group. Dose level: undiluted. No with. + reactions: 0.0. Total no. in groups: 20.0. Clinical observations: 2 animals found dead, one on Day 8 and one on Day 9.
- Reading:
- other: Epicutaneous challenge
- Hours after challenge:
- 72
- Group:
- test chemical
- Dose level:
- 75% v/v
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- 2 animals found dead, one on Day 8 and one on Day 9
- Remarks on result:
- other: Reading: other: Epicutaneous challenge. . Hours after challenge: 72.0. Group: test group. Dose level: 75% v/v. No with. + reactions: 0.0. Total no. in groups: 20.0. Clinical observations: 2 animals found dead, one on Day 8 and one on Day 9.
- Reading:
- other: Epicutaneous challenge
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 0
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: other: Epicutaneous challenge. . Hours after challenge: 24.0. Group: negative control. Dose level: 0. No with. + reactions: 0.0. Total no. in groups: 10.0.
- Reading:
- other: Epicutaneous challenge
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 0
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: other: Epicutaneous challenge. . Hours after challenge: 48.0. Group: negative control. Dose level: 0. No with. + reactions: 0.0. Total no. in groups: 10.0.
- Reading:
- other: Epicutaneous challenge
- Hours after challenge:
- 72
- Group:
- negative control
- Dose level:
- 0
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: other: Epicutaneous challenge. . Hours after challenge: 72.0. Group: negative control. Dose level: 0. No with. + reactions: 0.0. Total no. in groups: 10.0.
- Reading:
- other: Intradermal induction
- Hours after challenge:
- 24
- Group:
- positive control
- Dose level:
- 5% w/w
- No. with + reactions:
- 0
- Total no. in group:
- 10
Any other information on results incl. tables
- Intradermal induction: very slight to well-defined erythema (grades 1 -2) at 24 and 48 hours in all tst animals, no reactions in control group.
- Epicutaneous induction: very slight erythema (grade 1) with or without very slight oedema (grade 1) noted at 16 test animals after 1 hour, in 5 animals also after 24 hours. Very slight erythema (grade 1) noted in 7 control animals after 1 hour, very slight oedema (grade 1) noted in 1 control group animal after 1 hour.
- Epicutaneous challenge undiluted test substance: very slight erythema (grade 1) noted in 2 test animals after 24 hours, in 1 animal after 48 hours and in none of the animals after 72 hours. No skin reactions in control group at any time.
-Epicutaneous challenge 75% in acetone: No skin reactions were observed in all the challenge sites of test animals and controls at all time points.
- 17% of the test animals (3/18) showed a positive skin reaction at challenge. According to the test guideline this result can be regarded as negative as less than 30% of the animals showed a positive challenge reaction. The test material is therefore not a skin sensitizer under the conditions of this study.
2 animals died during the study for undefined reasons.
Body weight gains of the test group were comparable to those observed in the negative control group.
Applicant's summary and conclusion
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information
- Conclusions:
- The substance is not considered a skin sensitizer in this study.
- Executive summary:
In a dermal sensitization study, 2,2-bis(chloromethyl)trimethylene bis(bis(2-chloroethyl)phosphate) was tested in female albino Dunkin-Hartley guinea pigs according to OECD Test Guideline No.406 (guinea pig maximisation test). At challenge with the undiluted test substance 3 of 18 animals (17%) showed a slight skin reaction. None reacted positively in the group challenged with 75% of the test substance in acetone. According to the test guideline the substance is not considered a skin sensitizer in this study. Two test animals died during the study for undefined reasons. Body weight gains of the test animals were comparable to those of the negative controls.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.